EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age-linked DNA methylation and gene expression patterns in parameningeal head and neck alveolar rhabdomyosarcoma reveal CDK9 as a promising therapeutic target

Sara Patrizi, Silvia Vallese, Sabina Barresi, Matteo Cassandri, Isabella Giovannoni, Lucia Pedace, Luana Abballe, Flavia Vinciarelli, Celeste Antonacci, Alessandra Stracuzzi, Barbara Mancini, Ida Russo und 6 weitere

Pharmacological Research · 2025

DOI: 10.1016/j.phrs.2025.107767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2025. Verfasst von Sara Patrizi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Onco-Haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy. Electronic address: sara.patrizi@opbg.net. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Alveolar, DNA Methylation, Cyclin-Dependent Kinase 9, Head and Neck Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Fondazione Umberto Veronesi, Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Alveolar rhabdomyosarcoma (ARMS) primarily affects children in the first decade of life, but it can also occur during adolescence, typically with a more favorable prognosis. This study aimed to explore differences in DNA methylation (DNAm) and gene expression profiles that may account for the worse prognosis in younger patients; and to investigate possible new therapeutic targets. METHODS: We conducted whole-genome DNAm and transcriptome analyses on 10 parameningeal head and neck ARMS patients, including 4 patients under 1 year old and 6 over 10 years old. Among the differentially expressed genes, we focused on actionable therapeutic targets and confirmed their protein expression levels by immunohistochemistry. We validated the biological relevance of molecules of interest through functional experiments on rhabdomyosarcoma cell lines. RESULTS: DNAm profiles did not significantly differ across age groups, while gene expression was the primary driver of observed differences. Several enriched pathways characterized younger patients with respect to older ones, including FAS, Integrin, PI3 kinase, and p53 by glucose deprivation. Among actionable molecules, cyclin dependent kinase 9 (CDK9) emerged as a promising therapy target, highly expressed in younger patients. Of note, CDK9 inhibitors specifically inhibit cell growth in bi- and three-dimensional ARMS cellular models, both as a monotherapy and in combination with BRD4 inhibitors. CONCLUSION: Despite the small sample size, these findings suggest potential age-related molecular mechanisms and highlight candidate genes for further investigation as novel therapeutic targets. Notably, we identified CDK9 as a promising target, warranting further exploration in the context of ARMS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhabdomyosarcoma, AlveolarDNA MethylationCyclin-Dependent Kinase 9Head and Neck NeoplasmsHumansChildInfantMaleFemaleChild, PreschoolCell Line, TumorGene Expression Regulation, NeoplasticAge FactorsAdolescentProtein Kinase InhibitorsTranscriptomeAntineoplastic Agents

Stichwörter der Autor:innen

Alveolar RhabdomyosarcomaDNA methylationTranscriptome sequencing, Targeted therapies, CDK9

Substanzen

Cyclin-Dependent Kinase 9CDK9 protein, humanProtein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Onco-Haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy. Electronic address: sara.patrizi@opbg.net.
  • Pathology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy.
  • Onco-Haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy.
  • Pathology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome 00185, Italy.
  • Onco-Haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome 00168, Italy.
  • Onco-Haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome 00165, Italy. Electronic address: evelina.miele@opbg.net.

Förderung

  • Italian Association for Cancer Research
  • Fondazione Umberto Veronesi
  • Ministry of Health

Zitieren

APA

Patrizi, S., Vallese, S., Barresi, S., Cassandri, M., Giovannoni, I., Pedace, L., Abballe, L., Vinciarelli, F., Antonacci, C., Stracuzzi, A., Mancini, B., Russo, I., Di Giannatale, A., Rota, R., Alaggio, R., Locatelli, F., Milano, G. M., & Miele, E. (2025). Age-linked DNA methylation and gene expression patterns in parameningeal head and neck alveolar rhabdomyosarcoma reveal CDK9 as a promising therapeutic target. Pharmacological Research. https://doi.org/10.1016/j.phrs.2025.107767

Vancouver

Patrizi S, Vallese S, Barresi S, Cassandri M, Giovannoni I, Pedace L, et al. Age-linked DNA methylation and gene expression patterns in parameningeal head and neck alveolar rhabdomyosarcoma reveal CDK9 as a promising therapeutic target. Pharmacological Research. 2025. doi:10.1016/j.phrs.2025.107767

BibTeX
@article{Patrizi2025,
  author = {Patrizi, Sara and Vallese, Silvia and Barresi, Sabina and Cassandri, Matteo and Giovannoni, Isabella and Pedace, Lucia and Abballe, Luana and Vinciarelli, Flavia and Antonacci, Celeste and Stracuzzi, Alessandra and Mancini, Barbara and Russo, Ida and Di Giannatale, Angela and Rota, Rossella and Alaggio, Rita and Locatelli, Franco and Milano, Giuseppe Maria and Miele, Evelina},
  title = {Age-linked DNA methylation and gene expression patterns in parameningeal head and neck alveolar rhabdomyosarcoma reveal CDK9 as a promising therapeutic target},
  journal = {Pharmacological Research},
  year = {2025},
  doi = {10.1016/j.phrs.2025.107767}
}
Kostenlos starten →